Clinical Trials Directory

Trials / Terminated

TerminatedNCT01259986

Treatment of Vitiligo With Low-energy Visible Light Laser

Treatment of Recalcitrant Forms of Vitiligo With a Low-energy 635 nm Visible Light Laser

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
3 (actual)
Sponsor
Henry Ford Health System · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is the evaluate the efficacy of using a low-energy 635 nm visible light laser in the treatment of various recalcitrant forms of vitiligo.

Detailed description

Vitiligo is a pigmentary disorder characterized by depigmented and hypopigmented macules and patches. There are forms of vitiligo which are more resistant to treatment, including segmental vitiligo and acral vitiligo. Previous studies have shown that a low energy helium-neon (633 nm) laser can cause increased proliferation of melanocytes and repigmentation in segmental-type vitiligo. The goal of this study is to verify these results and show efficacy in other recalcitrant forms of vitiligo including acral vitiligo and post melanocyte-keratinocyte transplantation vitiligo.

Conditions

Interventions

TypeNameDescription
PROCEDURELaser treatmentLaser treatment of using 635 nm laser with a dose of 3.0 J/cm\^2 to small area (2cm x 2cm) of vitiligo once to twice a week for a total of 12 weeks.

Timeline

Start date
2010-10-01
Primary completion
2011-06-01
Completion
2012-09-01
First posted
2010-12-15
Last updated
2012-09-27

Source: ClinicalTrials.gov record NCT01259986. Inclusion in this directory is not an endorsement.